The objectives of the COST Action MB1103 ASL in Dementia(AID) are:

  • To harmonise and compare all existing ASL acquisition methods
  • To develop automatic image processing software to offer the best possible precision and reproducibility when comparing quantitative perfusion parameters
  • To establish clinical trials to compare results obtained from ASL to FDG-PET across several European countries
  • To validate the technology as a biomarker of disease onset and progression, and a possible trial outcome measure.